Penn’s gene therapy program has signed a 150,000 sq ft lease at a former GlaxoSmithKline property in King of Prussia
“The Penn transaction is an indicator that the entire region is benefiting from the research being done in our world-renowned institutions.”
Interius Therapeutics raises record-breaking Series A round
A two-year-old Philadelphia gene therapy company spun out of the University of Pennsylvania has raised $76 million
Rapid COVID-19 diagnostic test delivers accurate results within 4 minutes
A low-cost, rapid diagnostic test for COVID-19 developed by Penn Medicine provides COVID-19 results within four minutes with 90% accuracy.
PCI’s Managing Director leads panel discussion on Cellicon Valley with Penn Medicine faculty luminaries
On May 6th, as part of the Cellicon Valley '21 two-day event, John Swartley, Managing Director of PCI, joined Penn Medicine faculty to discuss the commercialization of CAR-T technology
Philly Tech Week: Innovation Lessons from the Frontiers of Healthcare
As part of Philly Tech Week 2021 and the Technical.ly Philly Introduced Conference, PCI and the Pennovation Center, hosted an educational webinar on the range of innovations emerging from Penn in the
Passage Bio wins the Life Sciences PA Deal of the Year Award
Life Sciences PA has announced that Passage Bio is the recipient of their 2021 Deal of the Year Award.
The Vaccine Trenches
Key breakthroughs leading to the powerful mRNA vaccines against COVID-19 were forged at Penn. That triumph was almost 50 years in the making, longer on obstacles than celebration, and the COVID-19 vac
MedCity Spotlight Video: How PCI is combating Covid-19
As part of MedCity's 2021 INVEST conference, Cesar de la Fuente, presidential assistant professor at the University of Pennsylvania, explains the value of the rapid low-cost diagnostic test he has dev